Observational study demonstrates that serum HIV RNA quantification correlates with disease progression in untreated patients, indicating its utility for clinical monitoring.
Human immunodeficiency virus (HIV) RNA was detected and quantified in the serum of HIV-seropositive individuals using the polymerase chain reaction (PCR) and a noninsotopic enzymelinked affinity assay. Of 55 HIV-infected patients who were not receiving therapy, serum HIV RNA was detected in 9 of 19 who were asymptomatic, 11 of 16 with AIDS-related complex (ARC), and 18 of 20 with ADIS, with copy number ranging from 102 to ⩾ 5 × 104/200 εl of serum based on a relationship between absorbance and known copy number of gag gene RNA. Linear regression analysis demonstrated a correlation between infectious titer in 42 patient sera cocultured with donor peripheral blood mononuclear cells (PBMC) and PCR product absorbance (r = .70, P < .01). Serum HIV RNA detected by PCR also correlated with serum p24 antigen prositivity, CD4 counts <400/mm3, and the presence of HIV-related symptoms or disease. Quantification of infectious HIV RNA in cell-free serum by PCR may be useful as a marker for disease progression or in monitoring antiviral therapy.
No takes yet. Share an insight, caveat, or question.
Holodniy et al. (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: